(Reuters) - Teva Pharmaceutical Industries Ltd on Thursday launched an asthma inhaler that will be the first direct competition to GlaxoSmithKline's best-selling Advair. Teva, which won U.S. approval ...
GAITHERSBURG, Maryland (Reuters) - U.S. regulatory advisers on Wednesday recommended strengthening safety warnings on GlaxoSmithKline Plc's asthma drug Serevent amid new reports of deaths in children ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback